DYSPORT Trademark

Trademark Overview

On Tuesday, December 16, 2008, a trademark application was filed for DYSPORT with the United States Patent and Trademark Office. The USPTO has given the DYSPORT trademark a serial number of 77633793. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, April 4, 2020. This trademark is owned by Ipsen Biopharm Limited. The DYSPORT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other botulinum toxin derivatives for skin care and the treatment of neurological disorders; pharmaceutical preparations containing botulinum toxin with specified component(s) of the toxin haemagglutin complex for skin care and the treatment of neurological disorders; Pharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; pharmaceutical preparations for the treatment and prevention of neuromuscular disorders; pharmaceutical preparations for the treatment and prevention of cervical dystonia, cerebral palsy, and spasticity
dysport

General Information

Serial Number77633793
Word MarkDYSPORT
Filing DateTuesday, December 16, 2008
Status800 - REGISTERED AND RENEWED
Status DateSaturday, April 4, 2020
Registration Number3759924
Registration DateTuesday, March 16, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 29, 2009

Trademark Statements

Goods and ServicesPharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other botulinum toxin derivatives for skin care and the treatment of neurological disorders; pharmaceutical preparations containing botulinum toxin with specified component(s) of the toxin haemagglutin complex for skin care and the treatment of neurological disorders; Pharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; pharmaceutical preparations for the treatment and prevention of neuromuscular disorders; pharmaceutical preparations for the treatment and prevention of cervical dystonia, cerebral palsy, and spasticity

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 19, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIpsen Biopharm Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWrexham LL139UF
GB
Party NameIpsen Biopharm Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWrexham LL139UF
GB
Party NameIpsen Biopharm Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWrexham LL139UF
GB

Trademark Events

Event DateEvent Description
Sunday, April 5, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, April 4, 2020REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, April 4, 2020REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, April 4, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, March 16, 2020TEAS SECTION 8 & 9 RECEIVED
Saturday, March 16, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Saturday, February 27, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, February 27, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, February 26, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, January 25, 2016TEAS SECTION 8 & 15 RECEIVED
Tuesday, March 16, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, December 29, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 29, 2009PUBLISHED FOR OPPOSITION
Monday, November 23, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, November 17, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 6, 2009EXAMINER'S AMENDMENT ENTERED
Thursday, November 5, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 5, 2009EXAMINERS AMENDMENT E-MAILED
Thursday, November 5, 2009EXAMINERS AMENDMENT -WRITTEN
Monday, November 2, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 2, 2009NON-FINAL ACTION E-MAILED
Monday, November 2, 2009NON-FINAL ACTION WRITTEN
Friday, October 16, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 16, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 15, 2009ASSIGNED TO LIE
Wednesday, October 7, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 7, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 7, 2009NON-FINAL ACTION E-MAILED
Friday, August 7, 2009NON-FINAL ACTION WRITTEN
Wednesday, July 22, 2009ASSIGNED TO EXAMINER
Monday, July 20, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 14, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 14, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 12, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 12, 2009NON-FINAL ACTION E-MAILED
Thursday, March 12, 2009NON-FINAL ACTION WRITTEN
Thursday, March 12, 2009ASSIGNED TO EXAMINER
Saturday, December 20, 2008NOTICE OF PSEUDO MARK MAILED
Friday, December 19, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

dysport toxin botulinum pharmaceutical treatment preparations disorders skin neurological containing prevention